Jeffrey Schwartz is a Partner of Bain Capital Life Sciences, where he is a founding member of the team. Prior to co-founding Bain Capital Life Sciences in 2016, he was a leader within the healthcare vertical of Bain Capital Private Equity. He currently is a board member of Gynesonics, Inc., QuVa Pharma, and Springworks Therapeutics. In addition, he currently sits on the board of the Commonwealth School, the Boston Medical Center Philanthropic Trust and Well Sense Health Plan.
Prior to joining Bain Capital, Mr. Schwartz served as an Equity Research Analyst at Lehman Brothers, working in both New York and London.
Mr. Schwartz received an MBA from The Wharton School at the University of Pennsylvania, where he was a Palmer Scholar. He graduated magna cum laude from Yale University with a BA in economics.